Journal of the American College of Cardiology
-
J. Am. Coll. Cardiol. · Oct 2003
Randomized Controlled Trial Multicenter Study Clinical TrialPercutaneous coronary intervention for cardiogenic shock in the SHOCK trial.
We examined the clinical, angiographic, and procedural characteristics determining survival after percutaneous coronary intervention (PCI) for cardiogenic shock. ⋯ Restoration of coronary blood flow is a major predictor of survival in cardiogenic shock. Benefit appears to extend beyond the generally accepted 12-h post-infarction window. Surgery should be considered in shock patients with severe mitral insufficiency or multivessel disease not amenable to relatively complete percutaneous revascularization.